MedTrace Logo

Vancomycin and Daptomycin Plus Cefazolin for Preoperative Vascular Surgery Prophylaxis

NCT00967941 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 169

Last updated 2020-02-28

Study results available
· View outcomes & findings →

Summary

This study prospectively selects the patients to examine the effectiveness of the investigators' current standard of prophylaxis prior to vascular surgery and to compare the effectiveness of vancomycin and daptomycin plus cefazolin in reducing infections in vascular surgical patients.

Conditions

  • MRSA Infections

Sponsors & Collaborators

  • CAMC Health System

    lead OTHER

Principal Investigators

  • Patrick Stone, M.D. · CAMC Medical Staff-with admitting privileges

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-08-31
Primary Completion
2009-06-30
Completion
2010-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00967941 on ClinicalTrials.gov